Pharmacologic cholinesterase inhibition improves survival in experimental sepsis*Stefan Hofer, Markus A. Weigand, Konrad A. Bode et al.|Critical Care Medicine|2008Cited by 161
Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell CytotoxicityKerstin Herzer, Peter H. Krammer, Christine S. Falk et al.|Journal of Virology|2003Cited by 129